ST
ARIA

Spot Trading’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Spot Trading’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-22,500
Closed -$141K – 4387
2015
Q4 		$141K Sell
22,500
-29,400
-57% -$193K ﹤0.01% 2665
2015
Q3 		$303K Buy
51,900
+15,100
+41% +$116K ﹤0.01% 2399
2015
Q2 		$304K Buy
36,800
+29,400
+397% +$260K ﹤0.01% 2436
2015
Q1 		$61K Sell
7,400
-297,200
-98% -$2.2M ﹤0.01% 3252
2014
Q4 		$2.09M Buy
304,600
+226,200
+289% +$1.41M 0.01% 1363
2014
Q3 		$423K Sell
78,400
-37,100
-32% -$217K ﹤0.01% 2673
2014
Q2 		$736K Sell
115,500
-396,500
-77% -$2.73M ﹤0.01% 2377
2014
Q1 		$4.13M Buy
512,000
+381,300
+292% +$2.97M 0.02% 975
2013
Q4 		$891K Buy
130,700
+85,600
+190% +$462K ﹤0.01% 2046
2013
Q3 		$830K Sell
45,100
-24,600
-35% -$478K 0.01% 2051
2013
Q2 		$1.22M Buy
+69,700
New +$1.24M 0.01% 1755

Other funds holding ARIA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Spot Trading's ARIA Position: Q3 2016 in Review

Spot Trading sold out of Ariad Pharmaceuticals Inc (ARIA) in Q3 2016, closing a stake of 20,700 shares — an estimated $153K sold.

Spot Trading first reported a position in ARIA in Q2 2013 and held it in 12 quarters. The position peaked at $723K in Q3 2014. 202 funds tracked by Wall St. Rank hold ARIA as of Q3 2016.

  • Spot Trading reported no remaining Ariad Pharmaceuticals Inc position as of Q3 2016 after selling out during the quarter.
  • Spot Trading sold 20,700 Ariad Pharmaceuticals Inc shares in Q3 2016, an estimated $153K.
  • Spot Trading first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 12 quarters.
  • Spot Trading's Ariad Pharmaceuticals Inc position peaked at $723K in Q3 2014.
  • 202 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q3 2016.

Based on Spot Trading's 13F filing for Q3 2016, filed 31 Oct 2016.